PT  - JOURNAL ARTICLE
AU  - Scheinman, Robert I.
AU  - Cogswell, Patricia C.
AU  - Lofquist, Alan K.
AU  - Baldwin, Albert S.
TI  - Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
AID  - 10.1126/science.270.5234.283
DP  - 1995 Oct 13
TA  - Science
PG  - 283--286
VI  - 270
IP  - 5234
4099  - http://science.sciencemag.org/content/270/5234/283.short
4100  - http://science.sciencemag.org/content/270/5234/283.full
SO  - Science1995 Oct 13; 270
AB  - Glucocorticoids are potent immunosuppressive drugs, but their mechanism is poorly understood. Nuclear factor kappa B (NF-κB), a regulator of immune system and inflammation genes, may be a target for glucocorticoid-mediated immunosuppression. The activation of NF-κB involves the targeted degradation of its cytoplasmic inhibitor, IκBα, and the translocation of NF-κB to the nucleus. Here it is shown that the synthetic glucocorticoid dexamethasone induces the transcription of the IκBα gene, which results in an increased rate of IκBα protein synthesis. Stimulation by tumor necrosis factor causes the release of NF-κB from IκBα. However, in the presence of dexamethasone this newly released NF-κB quickly reassociates with newly synthesized IκBα, thus markedly reducing the amount of NF-κB that translocates to the nucleus. This decrease in nuclear NF-κB is predicted to markedly decrease cytokine secretion and thus effectively block the activation of the immune system.